Skip to main content

Day: November 19, 2025

Brazil joint venture partner receives regulatory approval

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Nov. 19, 2025 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) reported today that Nice Capital Holdings Ltda. (“Nice”), a member of the Nimofast Group (“Nimofast’), has received regulatory approval to proceed with its joint venture with Questerre for the development of Parana Xisto SA (“PX Energy”), an oil shale production and refining company based in southern Brazil (the “Joint Venture”). The Brazilian Administrative Council for Economic Defense (“CADE”) issued a certificate yesterday for its final and non-appealable decision to approve the participation of Nice in the Joint Venture. Nice will acquire a 50% interest...

Continue reading

Econergy connects 52MW Resko solar project under Apple vPPA

TEL AVIV, Israel and WARSAW, Poland, Nov. 19, 2025 (GLOBE NEWSWIRE) — Econergy Renewable Energy Ltd. (TASE: ECNR), a leading European Independent Power Producer (IPP), has successfully connected its 52MW Resko solar project in Poland to the national electricity grid. The project is owned by a partnership in which Econergy UK (a subsidiary 75.24% owned by Econergy Renewable Energy Ltd.) who holds 51% and The Phoenix Insurance Company Ltd., which holds the remaining 49%. The project is expected to reach full commercial operation within 30 days. A Virtual Power Purchase Agreement (vPPA) was signed with Apple Inc., under which Apple will purchase approximately 75% of the project’s electricity output at a fixed price for 19 years from the start of commercial operation. The remaining 25% of energy generation will be sold on the wholesale...

Continue reading

Solar A/S: No. 15 2025 Major shareholder announcement

Pursuant to section 30 of the Danish Capital Markets Act, Solar A/S hereby announces that UBS AG today has informed Solar that following its purchase of shares on 14 November 2025, UBS AG’s holding of Solar B shares now totals 416,780 shares at DKK 100, corresponding to an ownership share of 5.21%. ContactsCEO Jens Andersen – tel. +45 79 30 02 01CFO Michael H. Jeppesen – tel. +45 79 30 02 62IR Director Dennis Callesen – tel. +45 29 92 18 11Facts about Solar Solar is a leading European sourcing and services company mainly within electrical, heating and plumbing, ventilation and climate and energy solutions. Our core business centres on product sourcing, value-adding services and optimisation of our customers’ businesses. We facilitate efficiency improvement and provide digital tools that turn our customers into winners....

Continue reading

High Roller to Participate at Benchmark 14th Annual Discovery One-on-One Conference

Las Vegas, Nevada, Nov. 19, 2025 (GLOBE NEWSWIRE) — High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller, Fruta, and Kassuuu, today announced that management will participate at the Benchmark 14th Annual Discovery One-on-One Conference being held December 4th, 2025 at the New York Athletic Club, New York, NY. During the event, Seth Young, Chief Executive Officer of High Roller, will be available for one-on-one meetings with investors throughout the day to discuss the Company’s strategic growth initiatives, market expansion plans, and forward-looking outlook for 2026. High Roller continues to strengthen its leadership position in the global online gaming industry through a commitment to innovation, player experience, and responsible gaming...

Continue reading

RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement

Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the receipt of a Notice of Award of a grant from the NIH/NINDS and entry into an Amended and Restated Patent License Agreement with the University of Wisconsin Research Foundation. Summary of the NIH/NINDS GABAkines Grant On September 23, 2025, RespireRx received a Notice of Award from the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), award number 1R44NS143576, under the Small Business Innovation Research (SBIR) program which was created by the U.S. Congress to strengthen the role of small innovative...

Continue reading

Havila Shipping ASA: Third quarter 2025 accounts

Summary Freight revenues amounted to NOK 149.3 million in Q3 2025, an increase of NOK 8.5 million compared to the corresponding period last year and a decrease of NOK 16.2 million compared to the previous quarter. The average rate of assignments and utilization in this quarter is lower than the previous quarter. Two vessels have been out of service for parts of the quarter for planned maintenance. Operating expenses were NOK 84.1 million in Q3 2025, an increase compared to Q3 2024 of NOK 2.9 million and approximately the same as in the previous quarter. The company had a profit before depreciation of NOK 72.5 million in Q3 2025, compared to NOK 69.0 million in Q3 2024.  Value adjustment of the company’s debt amounted to NOK 38.7 million in the third quarter this year compared to NOK – 30.5 million in the corresponding period last year. Profit...

Continue reading

Correction: Major shareholder announcement

Sending a correction as previous company announcement stated subsidiary but the entity mentioned is a fund under management by Parvus Asset Management Jersey Limited.In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that Parvus Asset Management Jersey Limited has notified the company that one of the funds under its management, Parvus European Opportunities Master Fund, now holds 3,967,640 shares, corresponding to 5.02% of the share capital. In total, Parvus Asset Management Jersey Limited controls 12.50% of the voting rights and share capital in Pandora A/S. ABOUT PANDORA Pandora is the world’s largest jewellery brand, specialising in the design, crafting and marketing of accessible luxury jewellery made from high-quality materials. Each piece is created to inspire self-expression, allowing...

Continue reading

SKYX To Supply its Technologies to a 340-Unit Townhome and Apartment Project in San Antonio, Texas Built by Prominent Developers Landmark Companies

SKYX is Expected to Supply 15,000 Units Including its Advanced Smart Plug & Play Technologies comprising Ceiling Lighting, Ceiling Fans, Recessed Lights, Down Lights, EXIT Signs, Emergency Lights, Indoor and Outdoor Wall Lights Among Other Advanced Smart Products Landmark Companies are Prominent Developers with 27 Years of Experience Building Tens of Thousands of Units, Specializing in Modern Homes and Buildings with Over 3,000 Units in Development in Texas, Florida, and Colorado, Among Other Locations SKYX and Landmark are Expected to Collaborate on Additional Upcoming Landmark Projects SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues Through Interchangeability, Upgrades, AI Services, Monitoring and Subscriptions, Among Others MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) — SKYX Platforms...

Continue reading

AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion

Provides Detailed Breakdown of TON Holdings, Strategic Acquisitions, and Partnerships Following $71 Million Financing including $18.5 Million in equity financing from financing partnerships to launch the Artificial Intelligence Compute Program and Telegram Cocoon Initiative New York, NY, Nov. 19, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp. (Nasdaq: ATON) (“AlphaTON” or the “Company”), a specialized digital asset technology company focused on the Telegram ecosystem, today issued a comprehensive update to shareholders regarding its balance sheet composition and strategic initiatives executed since the closing of its PIPE funding on September 25, 2025. The Company has aggressively deployed capital into high-conviction assets, establishing a robust foundation for long-term growth through a three-pillar strategy: Treasury Accumulation...

Continue reading

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR⍺ Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 Antagonist, Phase 2 start expected near term) The anticipated preclosing equity financing and an investment commitment from Factor Bioscience is expected to extend Tempest’s runway to mid 2027 and through potentially significant milestones Plan to proceed with execution of globally approved protocol for amezalpat in first-line HCC subject to additional resources or partnerships Matt Angel, Ph.D. to assume role of President and CEO and Stephen Brady to assume role of Chairman of the board of directors upon closing of the acquisitionBRISBANE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — In a transaction designed to both...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.